Kairos Pharma Ltd. share price logo

Kairos Pharma Ltd. Share Price

NYSE: KAPA

Small Cap

$0.62

(+0.16%)

as on

Kairos Pharma Ltd. Stock Performance

as on March 25, 2026 at 6:58 am IST

  • Day's Low

    $0.57
    $0.62
    downward going graph

    8.06%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.40
    $2.11
    downward going graph

    35.48%

    Downside

    240.32%

    Upside

    downward going graph

Kairos Pharma Ltd. share price movements today

Previous Close
$0.62
Open
$0.60
Volume
718.0K
Day's Low - High
$0.57 - $0.62
52 Week Low - High
$0.40 - $2.11

Kairos Pharma Ltd. Historical Returns

1 Month Return
-1.54 %
3 Month Return
-16.6 %
1 Year Return
-36.83 %
3 Year Return
0 %
5 Year Return
0 %

Kairos Pharma Ltd. Stock Fundamentals & Key Indicators

Check Kairos Pharma Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.4M

EPS (TTM)

-0.2

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-92.07%

Kairos Pharma Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kairos Pharma Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Kairos Pharma Ltd. image
Kairos Pharma Ltd.
NA$12.4MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Kairos Pharma Ltd. Stock including INR - Dollar returns

The Kairos Pharma Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Kairos Pharma Ltd. investment value today

Current value as on today

₹72,806

Returns

₹27,194

(-27.19%)

Returns from Kairos Pharma Ltd. Stock

₹36,735 (-36.73%)

Dollar Returns*

₹9,541 (+9.54%)

Kairos Pharma Ltd. Stock’s Investor Sentiment and Interest

Search interest for Kairos Pharma Ltd. Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:74% versus previous 30 day period

Kairos Pharma Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
-
0
0
0
Operating Income
0
0
-1
0
0
0
-1
-1
-1
-1
EBITDA
0
0
-1
0
0
0
-
-1
-1
-1
Interest Expense
0
0
0
0
0
0
-
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-1
0
0
-1
0
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-2
-
-
Net Income
0
0
-1
0
0
-1
0
-1
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kairos Pharma Ltd. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
-
0
0
0
0
Operating Income
-1
-1
0
-1
-2
EBITDA
-1
-1
0
-1
-1
Interest Expense
0
0
0
0
0
Depreciation
-
0
0
0
0
Income Before Tax
-1
-2
-1
-1
-2
Income Tax Expense
-
-
-
-
-2
Net Income
-1
-2
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Kairos Pharma Ltd. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
0
-1
0
0
-1
0
-1
-1
-1
Operating Cash Flow
0
0
0
0
-2
-1
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
5
0
3
0
3
Change in Cash
0
0
0
0
3
-1
2
0
2

Kairos Pharma Ltd. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-1
-1
-2
Operating Cash Flow
0
0
0
-3
Investing Cash Flow
0
-
-
-
Financing Cash Flow
0
0
0
5
Change in Cash
0
0
0
1

Insights on Kairos Pharma Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 52.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, KAPA stock has moved down by -45.7%

About Kairos Pharma Ltd.

Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company. It is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Its lead candidate, ENV105, is an antibody that targets CD105, a protein identified as a key driver of resistance to various cancer treatments. ENV105 focused on reversing drug resistance by targeting CD105 and restoring the effectiveness of standard therapies across multiple cancer types. ENV105 is in a Phase II clinical trial for castrate-resistant prostate cancer and a Phase I trial for lung cancer, with the trials aimed at addressing unmet medical needs. Its portfolio includes various drug therapies consisting of peptide and small molecule cancer immunotherapeutics KROS 101, 102, 201, 301, and 401 and therapeutic agents ENV 105 and 205.
OrganisationKairos Pharma Ltd.
Headquarters2355 Westwood Boulevard, Los Angeles, CA, United States, 90064
CEODr. John S. Yu M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Kairos Pharma Ltd.

Name

Title

Dr. John S. Yu M.D., Ph.D.

CEO, Chairman & Secretary

Mr. Douglas W. Samuelson CPA

Chief Financial Officer

Dr. Neil A. Bhowmick Ph.D.

Chief Scientific Officer

Dr. Ramachandran Murali Ph.D.

Vice President of Research & Development

FAQs

What is Kairos Pharma Ltd. share price today?

Kairos Pharma Ltd. share price today is $0.62 as on at the close of the market. Kairos Pharma Ltd. share today touched a day high of $0.62 and a low of $0.57.

What is the 52 week high and 52 week low for Kairos Pharma Ltd. share?

Kairos Pharma Ltd. share touched a 52 week high of $2.11 on and a 52 week low of $0.4 on . Kairos Pharma Ltd. stock price today i.e. is closed at $0.62,which is 70.62% down from its 52 week high and 55.00% up from its 52 week low.

What is Kairos Pharma Ltd.'s market capitalisation today?

Kairos Pharma Ltd. market capitalisation is $0.00T as on .

How to invest in Kairos Pharma Ltd. Stock (KAPA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kairos Pharma Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kairos Pharma Ltd. Shares that will get you 2.4194 shares as per Kairos Pharma Ltd. share price of $0.62 per share as on March 25, 2026 at 1:28 am IST.

What is the minimum amount required to buy Kairos Pharma Ltd. Stock (KAPA) from India?

Indian investors can start investing in Kairos Pharma Ltd. (KAPA) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Kairos Pharma Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kairos Pharma Ltd. share’s latest price of $0.62 as on March 25, 2026 at 1:28 am IST, you will get 16.1290 shares of Kairos Pharma Ltd.. Learn more about fractional shares .